We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTEN icon
951
Patterson-UTI
PTEN
$3.62B
$104K 0.01%
3,855
-673
-15% -$16.6K
FFG
952
DELISTED
FBL Financial Group
FFG
$104K 0.01%
+1,332
New +$95.7K
AMAG
953
DELISTED
AMAG Pharmaceuticals
AMAG
$104K 0.01%
2,997
+1,129
+60% +$33.7K
UNT
954
DELISTED
UNIT Corporation
UNT
$104K 0.01%
+3,879
New +$83.8K
HR
955
DELISTED
Healthcare Realty Trust Incorporated
HR
$104K 0.01%
3,427
-1,752
-34% -$53.4K
AGIO icon
956
Agios Pharmaceuticals
AGIO
$1.89B
$103K 0.01%
2,487
+1,851
+291% +$97.1K
BALL icon
957
Ball Corp
BALL
$16.9B
$103K 0.01%
+2,736
New +$106K
DAR icon
958
Darling Ingredients
DAR
$9.19B
$103K 0.01%
+7,932
New +$107K
FN icon
959
Fabrinet
FN
$18.7B
$103K 0.01%
+2,560
New +$107K
HIW icon
960
Highwoods Properties
HIW
$3.58B
$103K 0.01%
2,014
-2,637
-57% -$129K
RJF icon
961
Raymond James Financial
RJF
$34.7B
$103K 0.01%
2,220
-7,598
-77% -$336K
EGRX
962
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$103K 0.01%
+1,300
New +$94.4K
TER icon
963
Teradyne
TER
$60.9B
$102K 0.01%
4,029
-602
-13% -$14.3K
PDCE
964
DELISTED
PDC Energy, Inc.
PDCE
$102K 0.01%
1,403
+1,226
+693% +$84.3K
SJI
965
DELISTED
South Jersey Industries, Inc.
SJI
$102K 0.01%
+3,014
New +$94K
FRED
966
DELISTED
Fred's Inc
FRED
$102K 0.01%
5,504
+4,706
+590% +$50.9K
LFUS icon
967
Littelfuse
LFUS
$11.7B
$101K 0.01%
+667
New +$95.2K
NBTB icon
968
NBT Bancorp
NBTB
$2.77B
$101K 0.01%
+2,409
New +$89.6K
RDN icon
969
Radian Group
RDN
$5.21B
$101K 0.01%
5,640
+4,569
+427% +$68.6K
WAL icon
970
Western Alliance Bancorporation
WAL
$9.05B
$101K 0.01%
2,084
-2,014
-49% -$86.7K
WBMD
971
DELISTED
WebMD Health Corp.
WBMD
$101K 0.01%
2,026
+1,077
+113% +$55.7K
BNED icon
972
Barnes & Noble Education
BNED
$439M
$100K 0.01%
+87
New +$91.9K
DY icon
973
Dycom Industries
DY
$12.3B
$100K 0.01%
1,252
-1,599
-56% -$129K
QQEW icon
974
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.82B
$100K 0.01%
2,174
-13,026
-86% -$596K
SBS icon
975
Sabesp
SBS
$19.1B
$100K 0.01%
+59,594
New +$105K
37 38
39
40 41

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.